U.S. Markets open in 3 hrs, 59 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.47 10:12 AM EST | |
|---|---|---|
| Day High | 1.52 02:28 PM EST |
|
| Range | 0.05 |
| Volume | 9,088 | |
|---|---|---|
| 30-Day Avg Vol | 119,000 |
|
| Difference | -92.36% |
| Market Cap | 45.34 M | |
|---|---|---|
| Mkt Cap Chg | 2.08 M |
| Shares Out | 29.83 M | |
|---|---|---|
| % Shrs Traded | 0.03% | |
| 1yr EPS Est | -0.715 |
| 52-Wk Low | 0.4911 | |
|---|---|---|
| 52-Wk High | 1.64 |
|
| Range | 1.15 |
| Prev Close | 1.45 11/6/09 | |
|---|---|---|
| Today's Open | 1.48 | |
| Change | 2.07% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 30,400.00 |
| Revenue (LFY) | 7.10 M | |
|---|---|---|
| Earnings (LFY) | -25.10 M | |
| Earnings (MRQ) | -1.33 M | |
| Next Earn Est | -0.02 | |
| Next Earnings | 11/23/2009 |
|
| EPS (TTM) | -0.63 | |
| 1yr EPS Growth | -13.49% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -42.67 | |
| Beta | 1.38 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Avigen has decided to go back to pharmaceutical basics. The company has been focused on developing small-molecule drugs aimed at controlling severe pain, opiate addiction and withdrawal, and blood clotting. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.02 11/9/09 | — — |
—
—
|
| Last Quarter | -0.09 6/30/09 | -0.04 6/30/09 |
0.05
Beat
|
| 2 Quarters Ago | — 3/31/09 | -0.24 3/31/09 |
—
—
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 100,000.00 | 7.10 M |
| Gross Profit | — | 6.42 M |
| Operating Income | -1.90 M | -26.19 M |
| Net Income | -1.33 M | -25.10 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts